RP-6685

• CAT Number: I042749
• CAS Number: 2832047-80-8
• Molecular Formula: C22H14F7N5O
• Molecular Weight: 497.37
• Purity: ≥95%
• Synonyms: N-[3-(6-aminopyridazin-3-yl)prop-2-ynyl]-2-[3,5-bis(trifluoromethyl)pyridin-2-yl]-N-(4-fluorophenyl)acetamide
• InChI: InChI=1S/C22H14F7N5O/c23-14-3-6-16(7-4-14)34(9-1-2-15-5-8-19(30)33-32-15)20(35)11-18-17(22(27,28)29)10-13(12-31-18)21(24,25)26/h3-8,10,12H,9,11H2,(H2,30,33)
• InChIKey: LHFFKHVGAKIDNO-UHFFFAOYSA-N
• SMILES: C1=CC(=CC=C1N(CC#CC2=NN=C(C=C2)N)C(=O)CC3=C(C=C(C=N3)C(F)(F)F)C(F)(F)F)F

RP-6685（Cat No.:I042749）is an investigational small molecule designed to target and inhibit the activity of the protein kinase C (PKC) enzyme, which plays a significant role in regulating cell signaling, growth, and survival. PKC is involved in various diseases, including cancer, cardiovascular disorders, and neurological conditions. By selectively modulating PKC activity, RP-6685 aims to block the proliferation and survival of cancer cells, as well as mitigate disease progression in other conditions. Currently undergoing clinical trials, RP-6685 is being evaluated for its safety, efficacy, and potential in treating certain cancers and inflammatory diseases.